Profit taking weighed down shares of Eleven Biotherapeutics Inc. (Nasdaq: EBIO) 46 cents to close at $1.04.
Profit taking sinks Eleven Biotherapeutics
April 25, 2016 at 17:11 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|